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AbstrAct
MiR-200 family is an important regulator of epithelial-mesenchymal transition 
and has been implicated in human carcinogenesis. However, their expression 
and functions in human cancers remain controversial. In the work presented 
here, we showed that miR-200 family members were frequently down-regulated 
in hepatocellular carcinoma (HCC). Although all five members of miR-200 family 
inhibited ZEB1/2 expression in HCC cell lines, we showed that overexpression only of 
the miR-200b/200c/429 subfamily, but not the miR-200a/141 subfamily, resulted in 
impeded HCC cell migration. Further investigations led to the identification of RhoA 
and ROCK2 as specific down-stream targets of the miR-200b/200c/429 subfamily. We 
demonstrated that the miR-200b/200c/429 subfamily inhibited HCC cell migration 
through modulating Rho/ROCK mediated cell cytoskeletal reorganization and cell-
substratum adhesion. Re-expression of miR-200b significantly suppressed lung 
metastasis of HCC cells in an orthotopic liver implantation model in vivo. In conclusion, 
our findings identified the miR-200b/200c/429 subfamily as metastasis suppressor 
microRNAs in human HCC and highlighted the functional discrepancy among miR-200 
family members.
IntroductIon
Hepatocellular carcinoma (HCC) is a prevalent 
malignancy and ranks the third most fatal cancer 
worldwide [1]. However, the molecular mechanisms 
underlying the development and progression of HCC 
remain poorly understood. MicroRNA (miRNA), a class 
of endogenous small non-coding RNA, has increasingly 
been recognized as an important post-transcriptional 
gene regulator. In the past decade, thousands of miRNAs 
have been discovered and annotated in the human and 
vertebrate genomes. These miRNAs contribute to the 
regulation and fine-tuning of almost all major cellular 
processes, such as cellular differentiation, proliferation, 
migration and apoptosis [2]. Aberrant miRNA expression 
has been linked to various disease conditions, including 
cancers. In human HCC, miRNA deregulation is an early 
event in liver carcinogenesis and accumulation of miRNA 
deregulation contributes to disease progression and 
metastasis [3, 4]. 
MiR-200 family has recently been identified as 
a major regulator of epithelial-mesenchymal transition 
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(EMT). MiR-200 family consists of five evolutionarily 
conserved members located in two separate clusters in 
the human genome, with miR-200b, miR-200a, and miR-
429 mapped to chromosome 1p36 (thereafter, referred 
as 1p36 cluster), and miR-200c and miR-141 mapped 
to chromosome 12p13 (henceforth, indicated as 12p13 
cluster). MiR-200 family can also be sub-divided into two 
subfamilies according to their seed sequence homology, 
with miR-200a and miR-141 as a group (hereafter, 
denoted as miR-200a subfamily) and miR-200b, miR-
200c, and miR-429 as another group (henceforward, 
named as miR-200b subfamily) (Supplementary Figure 
1a) [5, 6]. These miR-200 family members negatively 
regulate the expression of transcription repressors 
ZEB1 and ZEB2. Loss of miR-200 family results in up-
regulation of ZEB1 and ZEB2 and consequently leads 
to transcriptional repression of E-cadherin to facilitate 
EMT [5-7]. Interestingly, ZEB1 and ZEB2 are also 
involved in the transcriptional repression of the miR-
200 family, thus the miR-200 family and ZEB1/2 form 
a double-negative feedback loop to regulate each other. 
The homeostatic expression between miR-200 family 
and ZEB1/2 is critical for maintaining the stability of 
epithelial or mesenchymal phenotype of cells. Aberrant 
expression of either miR-200 family or ZEB1/2 will 
therefore feed-forward to disrupt the equilibrium and 
result in epithelial-mesenchymal transition (EMT) or 
mesenchymal-epithelial transition (MET) [8, 9]. Since 
EMT is a crucial step in cancer metastasis, the miR-200 
family members have been considered as metastasis-
suppressive miRNAs. Nevertheless, the expression of the 
miR-200 family in human cancer remains contentious. 
Both down- and up-regulations of miR-200 family have 
previously been reported [10-14]. These inconsistent 
findings are speculated to be related to the heterogeneous 
nature of human cancers [15]. Also, the miR-200 family 
may play different roles in different cancers depending on 
their specific cellular contexts [15]. However, knowledge 
regarding the expression and functional implications of 
miR-200 family in human HCC is awaited for detailed 
elucidation.
results
Frequent down-regulation of mir-200 family in 
human Hccs
To interrogate the expression of miR-200 family 
members in human HCCs, we retrieved the data from 
our previous miRNA expression profiling of 20 pairs of 
primary HCCs and their corresponding non-tumorous 
livers [4]. As illustrated by the heat map diagram, all 
five members of miR-200 family were profoundly down-
regulated in human HCCs, suggesting that loss of miR-
200 family might play a role in liver carcinogenesis 
(Figure 1a). We reasoned that, at the expression level, the 
miR-200 family can be categorized into two groups based 
on the chromosomal locations in which two different up-
stream promoters are involved (Ch. 1p36 cluster and Ch. 
12p13 cluster), whereas, at the functional level, the miR-
200 family members are categorized into two other groups 
based on the sequence homology hence two distinct 
groups of targets involved (miR-200b subfamily and 
miR-200a subfamily) (Supplementary Figure 1a) [5, 6]. 
Therefore, as proof-of-concept, miR-200a, miR-200b, and 
miR-200c were selected to represent each subgroup for 
expression and functional studies (Supplementary Figure 
1b). We performed quantitative RT-PCR (qRT-PCR) to 
validate the expression of miR-200 family members in an 
expanded HCC cohort (n = 64) and found that, consistent 
to our miRNA profiling data, miR-200a, miR-200b, 
and miR-200c were all significantly down-regulated in 
primary HCC samples (Figure 1b, P < 0.001). Indeed, 
down-regulation (> 2-fold) of all the miR-200 family 
members was detected in approximately 80% of primary 
HCC cases, suggesting that loss of miR-200 expression 
was a common event in human HCCs (Figure 1c). 
Mir-200b subfamily suppressed Hcc cell growth 
and metastasis
By comparing the expression of miR-200 in a pair 
of HCC cell lines derived from the primary tumor and 
its portal vein metastasis of the same patient, we noted 
that the miR-200 family members were significantly 
down-regulated in the metastatic cell line (H2M) when 
compared to its non-metastatic counterpart (H2P), 
suggesting that loss of miR-200 family might play a 
role in HCC metastasis (Supplementary Figure 2). In 
line with this observation, we found that the expression 
levels of the miR-200 family in a panel of HCC cell lines 
showed an opposite trend with the E-cadherin expression, 
and transient overexpression of miR-200a, miR-200b, 
and miR-200c precursors were all able to suppress the 
ZEB1/2 expression. These findings recapitulated the 
previous reports and supported the negative regulatory 
functions of miR-200 family in ZEB1/2 mediated EMT 
(Supplementary Figure 3). 
To further investigate the functions of miR-
200 family in human HCC, miR-200a, miR-200b, 
and miR-200c were subcloned into a lenti-viral based 
expression vector (Supplementary Figure 4a) and stably 
overexpressed in HCC cell lines, BEL7402 and SMMC-
7721. The successful overexpression of mature miR-
200s in these stably infected cells was validated by GFP 
marker and qRT-PCR (Supplementary Figure 4b). In 
addition to the expression level, the post-transcriptional 
gene repressive functions of these ectopically expressed 
miR-200s were also confirmed by specific luciferase-
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tagged miRNA sensors (Supplementary Figure 4c). With 
these miR-200s stably overexpressing cells, we then 
investigated the effects of miR-200 family in HCC cell 
growth. Overexpression of miR-200b and miR-200c, 
but not miR-200a, resulted in a moderate but significant 
reduction on cell proliferation and also impeded anchorage 
independent growth on soft agar (Figure 2a and 2b). 
Surprisingly, we found that although miR-200a, miR-
200b and miR-200c all attenuated ZEB1/2 expression in 
HCC cells, only stable overexpression of miR-200b and 
miR-200c remarkably suppressed HCC cell migration. 
The migration rate of HCC cells overexpressing miR-
200a, was similar to the vector control (Figure 2c). 
This observation was reproducible by transiently 
Figure 1: Frequent down-regulation of mir-200 family in human Hccs. (a) Expression of the miR-200 family members in 
20 pairs of primary HCCs and their corresponding non-tumorous livers. Data were retrieved from TaqMan-Low density array miRNA 
profiling study [4]. Relative miRNA expression levels are presented in a heat-map diagram generated by GeneCluster and Treeview 
software. Unsupervised clustering analysis revealed a profound differential expression of the miR-200 family members in primary HCCs. 
(b) qRT-PCR analysis performed on an expand HCC cohort (n = 64) confirmed the significant down-regulation of the miR-200 family in 
human HCCs (P < 0.001, Wilcoxon test). NL: normal livers; NT: non-tumorous livers; HCC: primary hepatocellular carcinoma. (c) Down-
regulation of the miR-200 family (> 2 fold) was detected in 78%-86% of primary HCCs.
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overexpressing the miR-200 precursors in the same cell 
lines, thus ruling out the possibility of experimental 
artifacts that might be introduced by the lenti-viral vector 
or stable infection (Supplementary Figure 5). Altogether, 
these findings suggested that the miR-200a and miR-
200b subfamilies acted differentially, with the miR-200b 
subfamily members specifically functioning as tumor 
suppressors in HCC. 
Mir-200b subfamily negatively regulated rhoA 
and rocK2
The distinct function of miR-200a and miR-200b 
subfamilies on HCC cell growth and migration implied 
that miR-200b subfamily exerted its tumor suppressive 
functions via a mechanism beyond the inhibition of 
ZEB1/2 mediated EMT. To further investigate the down-
stream targets and molecular pathways specifically 
regulated by miR-200b subfamily, in-silico analysis was 
performed by using the EIMMO miRNA prediction server 
[16]. Among the 33,410 mRNA transcripts included in this 
analysis, 871 and 1488 mRNAs were predicted to harbor 
evolutionarily conserved binding site(s) of miR-200a 
and miR-200b subfamilies, respectively. Gene ontology 
(GO) analysis further revealed that the down-stream 
targets of miR-200a and miR-200b subfamilies were 
enriched in different GO terms (Supplementary Table 
1). Interestingly, we noted that the down-stream targets 
of the miR-200b subfamily were significantly enriched 
in cytoskeleton genes and participated in small GTPase 
mediated signal transduction (P = 1.15 × 10-5 and 4.30 × 
10-3, respectively). Among all, two major components of 
the cytoskeletal regulatory pathway, RhoA and ROCK2, 
were suggested as specific targets of the miR-200b 
subfamily by different miRNA target prediction algorithms 
Figure 2: effects of the mir-200 family on Hcc cell growth and migration. (a) Proliferation rate of miR-200 stably 
overexpressing cells. Cell number was counted by automatic cell counter in five consecutive days. Overexpression of miR-200b and 
miR-200c modestly suppressed HCC cell proliferation. (b) Anchorage independent growth of miR-200 stably overexpressing cells was 
assessed by colony formation assay in soft-agar. Both the size and number of colonies formed were significantly reduced in miR-200b- and 
miR-200c-overexpressing cells. (c) The effect of stable miR-200 overexpression on HCC cell migration in Transwell cell migration assay. 
Migrated cells were stained with crystal violet and counted under microscope. P-values were determined by t-test and comparing with the 
vector control, * P < 0.05, ** P < 0.01, *** P < 0.001
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(Supplementary Figure 6). To experimentally validate 
these in-silico prediction results, 3’UTRs of RhoA and 
ROCK2 were cloned into a luciferase reporter construct 
and co-transfected with miR-200 precursors in BEL7402. 
Luciferase reporter assays showed that overexpression 
of miR-200b or miR-200c precursors significantly 
suppressed the luciferase signals of RhoA- and ROCK2- 
3’UTR fusion reporters. These suppressive effects were 
significantly reduced in the miR-200a overexpressing 
cells or upon mutation of the miR-200b subfamily binding 
sequence, thus confirming the specificity of the miR-200b 
subfamily in regulating RhoA and ROCK2 expression 
(Figure 3a and 3b). In line with this observation, the 
endogenous expression of RhoA and ROCK2 mRNA 
was significantly inhibited in miR-200b- and miR-200c-
stably overexpressing BEL7402 cells when compared to 
the empty vector and miR-200a-stably overexpressing 
controls (Figure 3c and 3d). Similar findings were also 
observed at the protein levels as demonstrated by Western 
blotting (Figure 3e). Furthermore, we employed locked 
nucleic acid (LNA) miRNA inhibitors to specifically 
inhibit the expression of the miR-200 family members. 
Consistently, inactivation of miR-200b and miR-200c 
resulted in up-regulation of endogenous RhoA and 
ROCK2 protein expression in immortalized hepatocyte 
cell line, MIHA (Figure 3f). The above findings thus 
confirmed that miR-200b subfamily specifically targeted 
RhoA and ROCK2 3’UTRs and negatively regulated their 
expression at both mRNA and protein levels. 
Figure 3: Mir-200b subfamily negatively regulated rhoA and rocK2 expression. (a) and (b) Luciferase reporter assays. 
Wild-type and mutated RhoA or ROCK2 3’UTR were co-transfected with miR-200 precursors into BEL7402 cells. Overexpression of 
miR-200b and miR-200c significantly inhibited the luciferase activity associated with the wild-type 3’UTRs of RhoA and ROCK2. RLU: 
relative luciferase activity normalized with the empty miRNA luciferase reporter vector control. (c) and (d) qRT-PCR analysis showed that 
stable overexpression of miR-200b and miR-200c significantly inhibited endogenous RhoA and ROCK2 mRNA expression in BEL7402. 
(e) The endogenous RhoA and ROCK2 protein expression levels were reduced in miR-200b and miR-200c stably overexpressing cells. (f) 
Transient expression of miR-200 LNA inhibitors augmented endogenous RhoA and ROCK2 protein expression in immortalized hepatocyte 
cell line, MIHA. P-values were determined by t-test and compared to the corresponding vector control. * P < 0.05, ** P < 0.01, *** P < 
0.001.
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Mir-200b subfamily suppressed rho/rocK 
mediated cytoskeletal reorganization and cell 
motility
The identification of RhoA and ROCK2 as the miR-
200b subfamily targets prompted us to further investigate 
the roles miR-200b subfamily in HCC cytoskeletal 
reorganization. In this regard, immunofluorescence 
staining was performed to visualize the effects of miR-
200 family on Rho/ROCK mediated stress fiber and focal 
adhesion formations. We found that the formations of 
stress fibers (stained by Phallodin) and focal adhesions 
(stained by anti-paxillin antibody) were profoundly 
impeded in miR-200b- and miR-200c-overexpressing 
cells as compared to the empty vector and miR-200a-
overexpressing controls (Figure 4a and 4b). The loss 
of stress fiber and focal adhesion complex resulted in 
Figure 4: MiR-200b subfamily suppressed stress-fiber and focal adhesion formation mediated by Rho/ROCK in 
Hcc cells. (a) Stress-fibers (filaments across the cytosol) in miR-200 stably overexpressing BEL7402 cells were visualized by TRITC-
Phalloidin staining. (b) Focal adhesion complexes were stained up by anti-paxillin antibody. Stable overexpression of miR-200b and miR-
200c profoundly abolished the stress-fiber and focal adhesion formation and induced morphological change in BEL7402 cells. GFP maker 
was used to indicate the stable infection of miR-200 expression vectors. DAPI was used to counterstain the nuclei.
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dramatic morphological change of the miR-200b and 
miR-200c overexpressing cells (Figure 4), and the 
morphological change could be more clearly visualized 
under the scanning electron microscope (SEM) (Figure 
5a). The miR-200b and miR-200c overexpressing cells 
exhibited a rounded morphology, in contrast to a flat and 
extended morphology of the empty vector and miR-200a 
overexpressing cells (Figure 5a lower panel). Notably, 
the rounded cell morphology was more apparent when 
the cells were seeded on an uncoated glass coverslip as 
compared to the conventional “cell attachment enhanced” 
tissue culture plates. We therefore hypothesized that such 
morphological change reflected a loss of cell-substratum 
attachment ability and consequently hampered the cell 
motility of the miR-200b subfamily overexpressing 
cells. To address this question, we employed live cell 
imaging to monitor the cell-substratum attachment 
and non-directional random cell migratory abilities of 
BEL7402 cells. We found that the empty vector and 
miR-200a overexpressing cells were readily seeded 
onto the uncoated glass surface, exhibited an extended 
cell morphology and started to migrate within 12 hours, 
whereas miR-200b and miR-200c overexpressing cells 
failed to seed on the uncoated glass surface till the end 
of the experiment (Figure 5b and Supplementary Videos). 
Computer-aided cell migration tracking revealed that the 
cell migratory ability was modestly impaired in miR-
200a overexpressing cells when compared to the empty 
Figure 5: the mir-200b subfamily induced morphological change, attenuated cell-substratum adhesion and impeded 
cell migration in Hcc cells. (a) Cell morphology of miR-200 stably overexpressing BEL7402 cells was observed under phase-contrast 
microscope (20×) and scanning electron microscope (2500×). When seeded onto uncoated glass surfaces, miR-200b- and miR-200c-
overexpressing cells exhibited a rounded morphology as compared to the flat and extended morphology of miR-200a -overexpressing 
cells and empty vector controls. (b) Time-lapse microscope monitored the cell seeding during the first 24 hours. A delayed cell-substratum 
attachment was observed in miR-200b- and miR-200c-overexpressing cells. (c) Computer-aided cell migration path-tracking revealed a 
remarkable impairment of non-directional cell migration in miR-200b- and miR-200c-overexpressing cells. Lines representing the cell 
migratory paths of individual cells from their original positions (center). 
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control, but was drastically abolished in miR-200b 
and miR-200c overexpressing cells (Figure 5c). These 
findings collectively demonstrated the effects of the miR-
200b subfamily in regulating Rho/ROCK-mediated cell 
cytoskeletal reorganization and provided a mechanistic 
explanation to the specific tumor suppressive functions of 
the miR-200b subfamily in HCC. 
Mir-200b suppressed Hcc tumorigenicity and 
lung metastasis in mouse model
Since miR-200b subfamily was frequently down-
regulated in human HCC samples and negatively 
regulated HCC cell proliferation and migration in in 
vitro experiments, we sought to investigate whether 
overexpression of miR-200b is sufficient to suppress 
in vivo tumorigenicity and extrahepatic metastasis in 
mouse model. In this experiment, miR-200b and empty 
vector control were stably infected into luciferase labeled 
MHCC97L cells, which had a low miR-200b expression 
and exhibited frequent lung metastasis when orthotopically 
implanted into the livers of nude mice [17]. After 4 weeks 
of implantation, the size of tumors formed by the miR-
200b- overexpressing cells was significantly smaller 
that than of the vector controls (Figure 6a), although the 
rate of tumor formation was comparable between these 
two groups (75% [12/16] in vector control group versus 
65% [11/17] in the miR-200b-overexpressing group). 
Importantly, lung metastasis, as evidenced by ex-vivo 
bioluminescent imaging and histopathological analysis, 
was drastically reduced in miR-200b-overexpressing 
group. Lung metastasis was detected in only 27% (3/11) 
of the tumor bearing mice in the miR-200b overexpressing 
Figure 6: Mir-200b suppressed Hcc tumorigenicity and lung metastasis in mouse model. (a) Vector control and miR-200b 
stably overexpressing, luciferase-labelled MHCC97L cells were orthotopically implanted into the livers of the nude mice. After 4 weeks 
of inoculation, tumor formation was detected and quantified under in vivo bioluminescence imaging. Gross pathological examination was 
done on the tumor-bearing livers. Overexpression of miR-200b significantly suppressed the size of orthotopic tumors formed in nude mice. 
(b) The presence of lung metastasis was examined and quantitatively assessed in ex vivo bioluminescence imaging. Histopathological 
examination (H&E stain) was performed to confirm the presence of tumor foci formed in the lungs. Overexpression of miR-200b 
dramatically abolished the incidence and severity of lung metastasis in this in vivo orthotopic implantation model.
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group, whereas, in the control group, 67% (8/12) of the 
tumor bearing mice developed lung metastasis. Moreover, 
the number of metastasized cells, as quantified by the 
bioluminescence, was also significantly reduced upon 
overexpression of miR-200b (Figure 6b). The data 
obtained from this in vivo orthotopic implantation model 
echoed the findings of our in vitro studies and together 
provided strong evidence to support the tumor suppressive 
functions of miR-200b subfamily in human HCC. 
dIscussIon
In this study, we demonstrated that all five members 
of miR-200 family (miR-200a, miR-200b, miR-200c, 
miR-141 and miR-429) were frequently down-regulated 
in human HCCs as compared to their corresponding non-
tumorous livers. Consistent with our findings, down-
regulation of miR-200 family has been previously observed 
in HCC miRNA profiling and miR-200 expression studies 
reported by others [18-20], suggesting that loss of miR-
200 expression is a frequent event in liver carcinogenesis. 
MiR-200 family members are conventionally divided into 
two groups based on their genome locations clustered 
at 1p36 (miR-200a, miR-200b and miR-429) and 13p12 
(miR-200c and miR-141), respectively. MiR-200s in each 
cluster are likely co-regulated by a common promoter 
and may express as one polycistronic primary miRNA 
transcript [9]. In fact, we observed that the expression 
levels of mature miR-200a and miR-200b, both from the 
1p36 cluster, significant correlated with each other in both 
non-tumorous livers and primary HCCs (R2 = 0.691 and 
0.603, respectively, P < 0.001, linear regression). The 
down-stream targets to be regulated by a given miRNA 
are very much determined by the miRNA seed-sequence 
(nucleotide 2-8). The down-stream target repertoire of a 
miRNA collectively defines its functions within a specific 
cellular content [21]. In this sense, the miR-200 family can 
be sub-divided into the functionally miR-200a subfamily 
(miR-200a and miR-141) and miR-200b subfamily (miR-
200b, miR-200c and miR-429). In silico analyses have 
revealed that the down-stream targets of miR-200a and 
miR-200b subfamilies are largely non-overlapping with 
each other. Interestingly, we found that only the miR-200b 
subfamily members exerted tumor suppressive functions 
in HCC cells. Overexpression of miR-200b and miR-200c 
moderately suppressed HCC cell proliferation and colony 
formation, and drastically attenuated cell migration; all 
these effects were not seen in miR-200a overexpressing 
cells. These observations have raised two important issues. 
First, although the miR-200 family members are generally 
considered as functionally redundant paralogs, the miR-
200a and miR-200b subfamilies in fact have distinct 
functions in regulating HCC cell growth and migration. 
Co-expression of two functionally distinct miRNA 
subfamilies in a primary miRNA transcript may suggest a 
new level of regulation or evolutionary selection. Whether 
functional cross-talks exist between miR-200 subfamilies 
in both normal cells and during pathological conditions 
is an interesting question worthy to be further explored. 
Second, both miR-200a and miR-200b subfamilies share 
the negative regulatory function on ZEB1/2 but only miR-
200b subfamily suppressed HCC growth and migration, 
which implies that mechanisms in addition to the well-
characterized miR-200s/ZEB1/2/E-cadherin axis may be 
involved to empower tumor suppressive functions specific 
to the miR-200b subfamily in HCC. 
Attempting to address this question, in silico 
analyses were performed. In a pathway analysis, we 
found that down-stream targets of the miR-200b subfamily 
were specifically enriched in cytoskeleton proteins 
and participated in regulating small GTPase-mediated 
signal transduction. Among the candidate down-stream 
targets, we hypothesized that Rho-family small GTPase 
RhoA and its down-stream effector ROCK2 might be 
important for the miR-200b subfamily specific functions 
in HCC. RhoA and ROCK2 are the center of Rho/ROCK 
signaling pathway and are indispensable for actomyosin 
contraction, formation of stress fibers, and turnover of 
focal adhesions, thereby regulating cell movement [22, 
23]. The activity of RhoA is determined by its GTP 
binding status and can cycle between GTP-bound active 
and GDP-bound inactive forms through its intrinsic GTP 
hydrolysis activity. Activated RhoA binds to and releases 
auto-inhibitory structure of its effector kinases, ROCK1 
and ROCK2, and in turn, induces phosphorylation of 
multiple cytoskeletal proteins [22, 23]. The Rho/ROCK 
signaling pathway is frequently altered in human HCC 
by multiple mechanisms and consequently implicated in 
HCC metastasis. We previously reported that the RhoA 
up-stream regulators, DLC1 and DLC2 (deleted in liver 
cancer 1 and 2), were frequently down-regulated in human 
HCC by genetic deletion and epigenetic silencing [24, 25]. 
DLC1 and DLC2 are Rho-GTPase activating proteins 
(RhoGAP) which inactivate RhoA by promoting its GTP 
hydrolysis [24, 25]. Loss of DLC1 and DLC2 expression 
therefore leads to the hyperactivation of Rho/ROCK 
signaling pathway in human HCC [26]. In addition, we 
reported that ROCK2 but not ROCK1 was specifically up-
regulated in human HCC, which highlights the importance 
of ROCK2 in Rho/ROCK-mediated HCC tumorigenesis 
and metastasis [27]. More recently, we have further 
demonstrated that the frequent up-regulation of ROCK2 
was partially contributed by the loss of expression of its 
regulatory miRNA, miR-139 [17]. In the present study, 
using luciferase reporter assay, qRT-PCR, and Western 
blotting, we confirmed that the miR-200b sub-family 
interacted with RhoA and ROCK2 3’UTR and negatively 
regulated RhoA and ROCK2 expression at both mRNA 
and protein levels. Overexpression of the miR-200b 
subfamily significantly suppressed Rho/ROCK mediated 
cytoskeletal reorganization, as evidenced by the loss of 
stress fiber and focal adhesion formations, and induced 
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a dramatic cell morphological change. This phenotype 
was similar to the morphological change we observed 
in RhoA and ROCK2 knockdown cells (Supplementary 
Figures 7 and 8), strongly suggesting that this miR-200b-
mediated effect was attributed to the inactivation of Rho/
ROCK mediated cytoskeletal reorganization. We further 
demonstrated by live cell imaging that inactivation of 
Rho/ROCK signaling, through miR-200b subfamily 
overexpression, attenuated cell-substratum adhesion and 
consequently hampered cell migration. Altogether, these 
findings have uncovered a novel function of miR-200b 
subfamily in regulating Rho/ROCK mediated cytoskeletal 
reorganization and cell motility.
Finally, we employed an orthotopic implantation 
model to further demonstrate the functions of miR-200b 
in suppressing HCC tumorigenicity and metastasis in 
vivo. This model allows the HCC cells to form a tumor 
in a native liver microenvironment and metastasize to 
distant organs. The presence of luciferase reporter also 
facilitates the monitoring and quantitative measurement 
of orthotopic tumor growth and extra-hepatic metastasis 
in the mice. As expected, overexpression of miR-200b 
resulted in a modest inhibition of HCC cell growth in 
hepatic microenvironment. Importantly, the formation of 
lung metastasis was drastically abolished upon miR-200b 
overexpression. These findings coherently echoed with 
our in vitro findings and together confirmed the tumor 
suppressive functions of miR-200b subfamily in HCC. 
In summary, the work present here revealed that 
all the miR-200 family members were frequently down-
regulated in human HCC. Only the miR-200b subfamily 
but not its closely related miR-200a subfamily possessed 
tumor suppressor functions in HCC. The identification of 
RhoA and ROCK2 as the miR-200b subfamily specific 
targets highlighted the novel function of the miR-200b 
subfamily in regulating cytoskeletal organization. Our 
findings have demonstrated the functional discrepancy 
of miR-200 family members and provided a mechanistic 
explanation toward the miR-200b specific tumor 
suppressive function in HCC. 
MAterIAls And MetHods
Hcc patients and cell lines
Sixty-four patients who had primary HCC were 
involved in this study. Seventy-five percent of the patients 
had chronic HBV infection; the mean age was 54 ± 13 
years. The HCC and their corresponding non-tumorous 
liver samples were obtained from surgical resection at 
Queen Mary Hospital, Hong Kong. Normal liver samples 
were collected from patients who had resection of liver 
metastasis from colorectal carcinoma. Samples were 
immediately snap-frozen in liquid nitrogen and stored at 
-80°C for later use. Written consent was obtained from 
patients regarding the use of the specimens for scientific 
research. The use of clinical specimens for this study was 
approved by Institutional Review Board of the University 
of Hong Kong and the Hospital Authority of Hong Kong. 
Immortalized hepatocyte cell line, MIHA and 
human HCC cell lines, BEL7402 and SMMC-7721, were 
obtained from the Shanghai Institute of Cell Biology. 
Hep3B and HepG2 were purchased from American Type 
Culture Collection (ATCC). H2P and H2M cell lines were 
gifts from Dr XY Guan (the University of Hong Kong). 
Metastatic MHCC97L used for orthotopic implantation 
experiment was obtained from Dr. ZY Tang (Fudan 
University, Shanghai, China) and we labelled it with fire-
fly luciferase reporter as previously described [17]. 
MicroRNA profiling
MiRNA profiling was performed on 20 HCC patients 
with TaqMan Low-density array human microRNA set 2 
(Applied Biosystems) and has been reported previously 
[4]. In berify, miRNA was extracted from formalin-fixed, 
paraffin-embedded (FFPE) HCC and non-tumorous liver 
samples using miRNeasy FFPE kit (Qiagen, Valencia, 
CA). Mature miRNAs were reverse transcripted and 
pre-amplified with Megaplex-Pre-Amp reaction. Real-
time qunatitative PCR was then conduced with TaqMan 
Low density Array (TLDA) Human microRNA version 
2, as described in the manufacturer’s protocol (Applied 
Biosystems).
Quantitative reverse transcription polymerase 
chain reaction (qrt-Pcr)
Total RNA was extracted from clinical samples 
and cell lines using TRIZOL reagent (Life technologies). 
For protein coding genes and primary miRNAs, 
complementary DNA (cDNA) was synthesized from 
1µg of total RNA using the GeneAmp RNA PCR kit 
(Life Technologies) with random hexamer primers. 
PCR reactions were performed in ABI 7900HT Fast 
Real-Time PCR systems (Applied Biosystems) with the 
Power SYBR® Green Master Mix (Life technologies). 
For mature miRNAs, cDNA was synthesized from 10ηg 
of total RNA using the TaqMan MicroRNA Reverse 
Transcription Kit with miRNA specific stem-loop primers 
(Applied Biosystems). PCR reactions were performed 
in triplicate in 7900HT Fast Real-Time PCR systems 
(Applied Biosystems) with specific TaqMan MicroRNA 
assays (Applied Biosystems). GAPDH and RNU44 
were used as internal controls to normalize the relative 
expression levels of the protein coding genes and mature 
miRNAs, respectively. 
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Mir-200 family mirnA precursors and lnA 
inhibitors
1× 105 cells were seeded in 12-well plate a day 
before transfection. For miR-200 overexpression, the 
cells were transfected with 30 ηM of designated miRNA 
precursors or pre-miR negative control 1 (Applied 
Biosystems) using X-tremeGENE siRNA transfection 
reagent (Roche). For miR-200 inactivation, cells were 
transfected with 50 ηM designed miRCURY LNA™ 
miRNA Inhibitor or LNA control (Exiqon). 
establishment of mir-200s stably expressing cells
MiR-200a, miR-200b and miR-200c genes were 
amplified from the genomic DNA of MIHA cells and 
sub-cloned into a lenti-viral based miRNA expression 
vector, pCDH-CMV-MSC-EF1-copGFP/Puro (System 
Biosciences) utilizing the EcoRI and NotI restriction 
sites. Lenti-viral particles were packaged in 293FT cells 
with pPACK Packaging Systems (System Biosciences) 
and used to infect BEL7402, SMMC-7721 and luciferase-
labelled MHCC97L cells. Infected cells were then 
selected by 1µg puromycin for two weeks. The successful 
overexpression and post-translational gene regulatory 
activity of miR-200 family members in the stably infected 
cells were confirmed by qRT-PCR and luciferase reporter 
assays.
cell proliferation and colony formation assays
For cell proliferation assay, 1× 105 cells were 
seeded in 12-well plate a day before cell counting. The 
cell number was counted daily with Particle Counter 
(Beckman Coulter, Fullerton, CA) for five days. For 
colony formation assay, 5,000 cells were seeded onto 
6-well plates coated with soft agar. After incubation in a 
humidified incubator at 37°C for a month, the number of 
HCC cell colonies (> 100µm) formed was counted and 
pictured under microscope. 
cell migration assay
Migration assay was performed with 8.0µm-pore-
size Transwell inserts (Corning Inc., NY). 1× 105 cells 
resuspended in serum-free medium were seeded onto the 
upper chamber, and culture medium containing 10% FBS 
was added to the lower chamber as chemoattractant. After 
incubation in a humidified incubator at 37°C for 24 hr, 
the migrated cells were fixed, stained, and counted under 
microscope. 
In silico mirnA target prediction
MiRNA target prediction and Gene ontology (GO) 
analysis were performed using EIMMO miRNA prediction 
server (http://www.mirz.unibas.ch/ElMMo3/) [16]. The 
candidature of RhoA and ROCK2 as miR-200b subfamily 
specific targets was further evaluated by TargetScan5 
(http://www.targetscan.org) [28] and miRanda (http://
www.microrna.org) [29] algorithms.
 luciferase reporter assay
Wild-type and mutated miR-200b subfamily 
targeting sites on RhoA (132-153 nt.) and ROCK2 (1005-
1026 nt.) 3’UTR were cloned into a Dual-luciferase 
miRNA target expression vector pmirGLO (Promega). 
In addition, miRNA specific sensors containing the 
complementary sequences to individual mature miR-
200 family members were also cloned into the same 
vector and served as positive control for accessing the 
post-translational gene repression activity of ectopically 
expressed miR-200 family members. 5 × 104 HCC cells 
were seeded into each well of a 24-well plate the day 
before transfection. 15 ηM of each miR-200 precursors 
was first individually transfected into HCC cells using 
X-tremeGene. Twenty-four hours later, 0.5 µg of pmirGLO 
containing RhoA or ROCK2 3’UTR sequence was then 
transfected into the cells using FuGENE 6 (Roche). The 
firefly and Renilla luciferase activities of transfected 
cells were determined 48 hours after transfection using 
Dual-luciferase Assay Kit (Promega) according to the 
manufacturer’s protocol. Renilla luciferase activity was 
used as internal control for normalization.
Protein extraction and western blotting
Cells were lysed with 1% NP40 NET buffer for 
total protein extraction. Proteins were resolved in SDS-
PAGE and blotted onto nitrocellulose membrane. The 
membrane was incubated with primary antibody overnight 
at 4°C, followed by anti-mouse immunoglobulin G (GE 
Healthcare) for one hour at room temperature. The ECL 
detection system (GE Healthcare) was used for protein 
detection according to the manufacturer’s protocol. Anti-
E-cadherin and anti-ROCK2 antibodies were purchased 
from Santa Cruz Biotechnology, anti-RhoA antibody 
from Cytoskeleton and anti-β-actin antibody from Sigma-
Aldrich.
Immunofluorescence staining and scanning 
electron microscopy
1 x 104 cells were seeded on glass coverslips in 12-
well plates. After seeding, cells were serum starved for 24 
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hr. Cells were treated with 10µM lysophosphatidic acid 
for 30 minutes and then fixed with 4% paraformaldehyde 
in PBS and permeabilized with 0.2% Triton-X-100. 
F-actin was visualized by staining with TRICT 
conjugated phalloidin (Sigma Aldrich). Focal adhesions 
were stained with anti-paxillin antibody (Millipore). 
Nuclei were counter-stained with DAPI (Calbiochem). 
Immunofluorescence images were captured under Leica 
Q550CW fluorescence microscope (Leica) at 100× 
magnification. For scanning electron microscopy, cells 
were fixed with 2.5% glutaraldehyde and 1% osmium 
tetroxide. Fixed cells were then subjected to stepwise 
ethanol dehydration and critical point drying. Images were 
scanned and captured under 2,500× magnification using 
a Hitachi S-4800 FEG Scanning Electron Microscope 
(Hitachi).
time-lapse microscopy
Cells were plated in 12-well glass-bottomed imaging 
plates (MatTek) and cultured in CO2-independent medium 
(Invitrogen). Cell images were acquired using the Nikon 
TE2000-PFS inverted microscope (Nikon) enclosed in 
a humidified chamber maintained at 37°C. Cells were 
imaged every 10 minutes immediately after cell seeding 
with a 20× objective on five randomly selected fields 
per sample. Videos were generated with MetaMorph 
software (Molecular devices). For cell tracking analysis, 
the migration paths of 100 cells per sample were traced 
between 18 to 72 hours after cell seeding. Data were 
analyzed by Image-Pro Plus 6.0 (MediaCybernetics).
In vivo orthotopic implantation model
MiR-200b stably expressing cells were established 
from luciferase labelled MHCC97L cells [17]. 2 × 106 cells 
were resuspended in 25 µL DMEM-HG/Matrigel (BD 
Biosciences) at 1:1 ratio and orthotopically injected into 
the left liver lobe of 6-8 weeks old male BALB/cAnN-
nude mice. Mice were sacrificed at week 4 and in vivo 
tumor growth and lung metastasis were accessed by IVIS 
100 Imaging System (Xenogen). All animal experiments 
were performed according to the Control of Animals 
Experiments Ordinance (Hong Kong) and the Institute’s 
guidelines on animal experimentation. 
statistical analysis
Statistical analyses were performed using PRISM5 
software (GraphPad). P values less than 0.05 were 
considered statistically significant.
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